CVR: 32292402
Secondary names: ANESIDORA ApS
C4PAIN ApS is a Danish company of the type Anpartsselskab based in Aalborg, founded in 2009. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Lars Arendt-Nielsen. The company is owned by BIO-MEDICAL CONSULT HOLDING ApS. The company has 0 employees. In 2025, the company reported a gross profit of DKK 159,243 and a net result of DKK 185,909 compared with DKK 1,074,600 the year before. Equity amounted to DKK 4,164,765.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at etablere og udføre visse forskningsaktiviteter for selskabets medicinal- og biotekklienter samt forskning, in-licensering og klinisk udvikling af compounds til smertebehandling.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 159 t. | 186 t. | 4.4 mio. | 4.2 mio. | 1 | |
| 2024 | 1.3 mio. | 1.1 mio. | 4.4 mio. | 4 mio. | - | |
| 2023 | 28 t. | 97 t. | 3 mio. | 2.9 mio. | - | |
| 2022 | 252 t. | 237 t. | 2.9 mio. | 2.8 mio. | - | |
| 2021 | 53 t. | 70 t. | 2.6 mio. | 2.6 mio. | - | |
| 2020 | 658 t. | 542 t. | 2.8 mio. | 2.5 mio. | - | |
| 2019 | 474 t. | 400 t. | 2.2 mio. | 2 mio. | - | |
| 2018 | 1.8 mio. | 1.4 mio. | 2 mio. | 1.6 mio. | - | |
| 2017 | 666 t. | 660 t. | 820 t. | 812 t. | - | |
| 2016 | -453 t. | -374 t. | 1.5 mio. | 152 t. | - | |
| 2015 | -405 t. | -235 t. | 559 t. | 526 t. | - | |
| 2014 | 285 t. | 241 t. | 1.3 mio. | 761 t. | - | |
| 2013 | -448 t. | 1.6 mio. | 2.8 mio. | 520 t. | - | |
| 2012 | 2.1 mio. | -386 t. | 8.5 mio. | 2.7 mio. | - |
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreCompared to 1.056 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
C4PAIN ApS has published its annual report for 2025. Gross profit came to DKK 159,243, and the net result was DKK 185,909.
C4PAIN ApS has published its annual report for 2024. Gross profit came to DKK 1,257,321, and the net result was DKK 1,074,600.
C4PAIN ApS has published its annual report for 2023. Gross profit came to DKK 27,665, and the net result was DKK 96,580.
As of June 28, 2024, REDMARK, GODKENDT REVISIONSPARTNERSELSKAB has stepped down as auditor of C4PAIN ApS.
C4PAIN ApS has published its annual report for 2022. Gross profit came to DKK 252,356, and the net result was DKK 237,464.
C4PAIN ApS has published its annual report for 2021. Gross profit came to DKK 52,952, and the net result was DKK 70,244.
C4PAIN ApS has published its annual report for 2020. Gross profit came to DKK 658,252, and the net result was DKK 541,607.
C4PAIN ApS has published its annual report for 2019. Gross profit came to DKK 474,060, and the net result was DKK 399,804.
C4PAIN ApS has published its annual report for 2018. Gross profit came to DKK 1,764,830, and the net result was DKK 1,405,792.
As of January 1, 2019, BIO-MEDICAL CONSULT HOLDING ApS is registered as an owner of C4PAIN ApS with an ownership share of 100%.
C4PAIN ApS has published its annual report for 2017. Gross profit came to DKK 665,845, and the net result was DKK 659,611.
C4PAIN ApS has published its annual report for 2016. Gross profit came to DKK -453,434, and the net result was DKK -373,938.
C4PAIN ApS has published its annual report for 2015. Gross profit came to DKK -404,558, and the net result was DKK -234,519.
As of May 2, 2016, REDMARK, GODKENDT REVISIONSPARTNERSELSKAB has been appointed auditor of C4PAIN ApS.
As of May 2, 2016, REVISIONSFIRMAET PETER KRISTENSEN has stepped down as auditor of C4PAIN ApS.
As of May 2, 2016, Lars Arendt-Nielsen is registered as adm. dir. of C4PAIN ApS.
As of May 2, 2016, Hans Christian Hoeck has stepped down as adm. dir. of C4PAIN ApS.
C4PAIN ApS has published its annual report for 2014. Gross profit came to DKK 285,360, and the net result was DKK 240,807.
As of October 23, 2014, Lars Arendt-Nielsen has left the board of directors of C4PAIN ApS.
As of October 23, 2014, Claus Henrik Christiansen has left the board of directors of C4PAIN ApS.
As of October 23, 2014, Henrik Bernt Sanders has left the board of directors of C4PAIN ApS.
C4PAIN ApS has published its annual report for 2013. Gross profit came to DKK -448,496, and the net result was DKK 1,596,308.
C4PAIN ApS has published its annual report for 2012. Gross profit came to DKK 2,115,047, and the net result was DKK -385,626.
As of January 14, 2011, Charles-Hervé Girsault has left the board of directors of C4PAIN ApS.
As of October 19, 2009, REVISIONSFIRMAET PETER KRISTENSEN has been appointed auditor of C4PAIN ApS.
As of October 19, 2009, Ankjær-Jensen & Partnere I/S, Statsautoriserede Revisorer has stepped down as auditor of C4PAIN ApS.
As of July 21, 2009, Ankjær-Jensen & Partnere I/S, Statsautoriserede Revisorer has been appointed auditor of C4PAIN ApS.
As of July 21, 2009, Lars Arendt-Nielsen has joined the board of directors of C4PAIN ApS.
As of July 21, 2009, Claus Henrik Christiansen has joined the board of directors of C4PAIN ApS.
As of July 21, 2009, Henrik Bernt Sanders has joined the board of directors of C4PAIN ApS.
As of July 21, 2009, Charles-Hervé Girsault has joined the board of directors of C4PAIN ApS.
As of July 21, 2009, Hans Christian Hoeck is registered as adm. dir. of C4PAIN ApS.
C4PAIN ApS was founded on July 21, 2009.
Companies in the same industry and area
CVR 46023234
CVR 46279301
CVR 35053468
CVR 37516732
CVR 25155084
companydata.dk